ANTH:Anthera Pharmaceuticals Inc - Stock Price Quote and Dividend Data

LATEST CLOSE STOCK PRICE

$0.03

EXCHANGE

OTCBB

SECTOR

Health Care

ANTH

Anthera Pharmaceuticals Inc Dividend Information

Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Stock Split Date & Factor Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970

ANTH

Anthera Pharmaceuticals Inc Stock Price Information

Latest Close Stock Price$0.03
52-Week Low/High Stock Price$0.02 - $0.08
Percent Held by Institutions5.35%
Revenue$0
Net Income$-31,115,000
Cash Flow$-9,381,000
EPS-0.42%
Market Cap$706,833

PE Ratio0
PE Ratio to Industry35%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.18%
Total Return Last 12 Months-53.80%
Total Return Last 3 Years-98.39%
Total Return Last 5 Years-99.94%
Latest Trade DateJun. 01, 2020

ANTH

Anthera Pharmaceuticals Inc Dividend Payment History

No Data available for Payment History.

ANTH

Anthera Pharmaceuticals Inc Other Details

Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of medicines that benefit patients with medical needs. Co. has two compounds in development, Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy.

Web Sitewww.anthera.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking

Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone

Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends: